AMBulatory UltraSound for Heart Failure Management

Recruiting N/A Interventional Study
Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
182 (estimated)
Sponsor
Central Hospital, Nancy, France · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
AMBUSH study is a multicenter randomized, controlled, open-label clinical trial (PROBE (Prospective Randomized Open Blinded End-point) type). The main objective of AMBUSH study is to assess the effect of therapeutic management guided by pulmonary ultrasound and the assessment of the inferior vena cava in patients with heart failure seen in an ambulatory (outpatient) setting on a mixed clinical-bi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male or female aged 18 and over * Heart failure (regardless of left ventricular ejection fraction) * Diagnosis of heart failure established more than 3 months ago * Absence of significant clinical signs of congestion on clinical examination (absence of crackles and lower limbs…
Contacts

Nicolas GIRERD, MD,PhD

+33 3 83 15 74 96

n.girerd@chru-nancy.fr

CONTACT